# Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression

> **NCT06325605** · NA · COMPLETED · sponsor: **Zhen-Hong Hu** · enrollment: 100 (actual)

## Conditions studied

- Adolescent Depression

## Interventions

- **DRUG:** Bifidobacterium
- **DEVICE:** High-frequency rTMS
- **DRUG:** Escitalopram Oxalate

## Key facts

- **NCT ID:** NCT06325605
- **Lead sponsor:** Zhen-Hong Hu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-01
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06325605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06325605, "Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06325605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*